Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of clevidipine for perioperative blood pressure management in pediatric patients
2013-001268-44Phase 4
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clevidipine in hypertension (HTN) and None, sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Time and dose to reach initial target systolic blood pressure range.
02
Drugs
clevidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2013-001268-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001268-44.